The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus

Objective. Closed-loop insulin systems represent a technological advance in diabetes management but have rarely been studied in pregnancy. We report a case of a patient with type 1 diabetes mellitus who was previously a user of the Paradigm VEO pump and then migrated to Medtronic 670G. Research Desi...

Full description

Bibliographic Details
Main Authors: Guillermo E. Guzmán Gómez, Julian A. Viggiano, A. Silva-De Las Salas, Veline Martínez, María A. Urbano Bonilla
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2021/7310176
_version_ 1798031590058622976
author Guillermo E. Guzmán Gómez
Julian A. Viggiano
A. Silva-De Las Salas
Veline Martínez
María A. Urbano Bonilla
author_facet Guillermo E. Guzmán Gómez
Julian A. Viggiano
A. Silva-De Las Salas
Veline Martínez
María A. Urbano Bonilla
author_sort Guillermo E. Guzmán Gómez
collection DOAJ
description Objective. Closed-loop insulin systems represent a technological advance in diabetes management but have rarely been studied in pregnancy. We report a case of a patient with type 1 diabetes mellitus who was previously a user of the Paradigm VEO pump and then migrated to Medtronic 670G. Research Design and Methods. We reviewed the case of a G1P0 patient with type 1 diabetes, treated with the Medtronic 670G system during pregnancy; a comparison with current literature was done. Results. The patient achieved improved glycemic control as measured by time spent in different ranges as follows: <70 mg/dL, 8–4% and 70–180 mg/dL, 83–94%. Secondary outcomes included reduction of stress, anxiety, fear of hypoglycemia, and the psychological burden related to the disease. There were no obstetric or neonatal complications. Conclusion. The Medtronic 670G closed-loop system was used safely in a pregnant woman; nevertheless, further research is needed to validate this system in this patient population.
first_indexed 2024-04-11T20:00:09Z
format Article
id doaj.art-365650aeb67f4ae5938f661a0268b3c0
institution Directory Open Access Journal
issn 2090-6501
2090-651X
language English
last_indexed 2024-04-11T20:00:09Z
publishDate 2021-01-01
publisher Hindawi Limited
record_format Article
series Case Reports in Endocrinology
spelling doaj.art-365650aeb67f4ae5938f661a0268b3c02022-12-22T04:05:40ZengHindawi LimitedCase Reports in Endocrinology2090-65012090-651X2021-01-01202110.1155/2021/73101767310176The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes MellitusGuillermo E. Guzmán Gómez0Julian A. Viggiano1A. Silva-De Las Salas2Veline Martínez3María A. Urbano Bonilla4Fundación Clínica Valle del Lili, Department of Endocrinology, Universidad Icesi, Cali, ColombiaPGY3 Internal Medicine Resident, Fundación Clínica Valle del Lili, Universidad Icesi, Cali, ColombiaUniversidad Icesi, Cali, ColombiaFundación Clínica Valle del Lili, Department of Internal Medicine, Universidad Icesi, Cali, ColombiaFundación Clínica Valle del Lili, Clinical Investigations Center, Cali, ColombiaObjective. Closed-loop insulin systems represent a technological advance in diabetes management but have rarely been studied in pregnancy. We report a case of a patient with type 1 diabetes mellitus who was previously a user of the Paradigm VEO pump and then migrated to Medtronic 670G. Research Design and Methods. We reviewed the case of a G1P0 patient with type 1 diabetes, treated with the Medtronic 670G system during pregnancy; a comparison with current literature was done. Results. The patient achieved improved glycemic control as measured by time spent in different ranges as follows: <70 mg/dL, 8–4% and 70–180 mg/dL, 83–94%. Secondary outcomes included reduction of stress, anxiety, fear of hypoglycemia, and the psychological burden related to the disease. There were no obstetric or neonatal complications. Conclusion. The Medtronic 670G closed-loop system was used safely in a pregnant woman; nevertheless, further research is needed to validate this system in this patient population.http://dx.doi.org/10.1155/2021/7310176
spellingShingle Guillermo E. Guzmán Gómez
Julian A. Viggiano
A. Silva-De Las Salas
Veline Martínez
María A. Urbano Bonilla
The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus
Case Reports in Endocrinology
title The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus
title_full The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus
title_fullStr The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus
title_full_unstemmed The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus
title_short The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus
title_sort closed loop system improved the control of a pregnant patient with type 1 diabetes mellitus
url http://dx.doi.org/10.1155/2021/7310176
work_keys_str_mv AT guillermoeguzmangomez theclosedloopsystemimprovedthecontrolofapregnantpatientwithtype1diabetesmellitus
AT julianaviggiano theclosedloopsystemimprovedthecontrolofapregnantpatientwithtype1diabetesmellitus
AT asilvadelassalas theclosedloopsystemimprovedthecontrolofapregnantpatientwithtype1diabetesmellitus
AT velinemartinez theclosedloopsystemimprovedthecontrolofapregnantpatientwithtype1diabetesmellitus
AT mariaaurbanobonilla theclosedloopsystemimprovedthecontrolofapregnantpatientwithtype1diabetesmellitus
AT guillermoeguzmangomez closedloopsystemimprovedthecontrolofapregnantpatientwithtype1diabetesmellitus
AT julianaviggiano closedloopsystemimprovedthecontrolofapregnantpatientwithtype1diabetesmellitus
AT asilvadelassalas closedloopsystemimprovedthecontrolofapregnantpatientwithtype1diabetesmellitus
AT velinemartinez closedloopsystemimprovedthecontrolofapregnantpatientwithtype1diabetesmellitus
AT mariaaurbanobonilla closedloopsystemimprovedthecontrolofapregnantpatientwithtype1diabetesmellitus